Company Page
Most Recent Insiders Activity
| Transaction Date | Company Name | Insider Name (Title) | Activity | Stock | Acquired or Disposed | Shares | Price range | Amount |
|---|---|---|---|---|---|---|---|---|
| 2024-03-28 | Olema Pharmaceuticals, Inc. | Harmon Cyrus
(Director) |
S | Common Stock | D | 20000 | $10.97 - $10.97 | $219,400 |
| 2024-03-18 | Olema Pharmaceuticals, Inc. | Zojwalla Naseem
(CHIEF MEDICAL OFFICER) |
M | Common Stock | A | 13700 | $4.87 - $4.87 | $66,719 |
| 2024-03-05 | Olema Pharmaceuticals, Inc. | RAPPAPORT ANDREW
(Director) |
J | Common Stock | D | 866979 | $0.00 - $0.00 | $0 |
| 2024-01-25 | Olema Pharmaceuticals, Inc. | Zojwalla Naseem
(CHIEF MEDICAL OFFICER) |
M | Common Stock | A | 20000 | $7.02 - $7.02 | $140,400 |
| 2024-01-12 | Olema Pharmaceuticals, Inc. | Kovacs Shane Will...
(CH. OPERATING & FINANCIAL OFF.) |
M | Common Stock | A | 50000 | $7.02 - $7.02 | $351,000 |
| 2023-12-29 | Olema Pharmaceuticals, Inc. | Harmon Cyrus
(Director) |
S | Common Stock | D | 25000 | $13.30 - $14.10 | $334,500 |
| 2023-11-30 | Olema Pharmaceuticals, Inc. | Harmon Cyrus
(Director) |
S | Common Stock | D | 25000 | $12.57 - $12.57 | $314,250 |
| 2023-11-21 | Olema Pharmaceuticals, Inc. | Harmon Cyrus
(Director) |
S | Common Stock | D | 8181 | $13.90 - $14.86 | $117,740 |
| 2023-11-20 | Olema Pharmaceuticals, Inc. | Harmon Cyrus
(Director) |
A | Common Stock | A | 15750 | $0.00 - $0.00 | $0 |
| 2023-11-21 | Olema Pharmaceuticals, Inc. | Zojwalla Naseem
(CHIEF MEDICAL OFFICER) |
S | Common Stock | D | 14556 | $13.89 - $15.33 | $209,295 |
| 2023-11-20 | Olema Pharmaceuticals, Inc. | Zojwalla Naseem
(CHIEF MEDICAL OFFICER) |
A | Common Stock | A | 28000 | $0.00 - $0.00 | $0 |
| 2023-11-21 | Olema Pharmaceuticals, Inc. | Myles David C.
(CH. DISCOV. & NON-CLIN DEV OFF) |
S | Common Stock | D | 13629 | $13.89 - $15.32 | $196,233 |
| 2023-11-20 | Olema Pharmaceuticals, Inc. | Myles David C.
(CH. DISCOV. & NON-CLIN DEV OFF) |
A | Common Stock | A | 26250 | $0.00 - $0.00 | $0 |
| 2023-11-21 | Olema Pharmaceuticals, Inc. | Bohen Sean
(PRESIDENT AND CEO) |
S | Common Stock | D | 57225 | $13.90 - $15.29 | $824,132 |
| 2023-11-20 | Olema Pharmaceuticals, Inc. | Bohen Sean
(PRESIDENT AND CEO) |
A | Common Stock | A | 110250 | $0.00 - $0.00 | $0 |
| 2023-11-21 | Olema Pharmaceuticals, Inc. | Kovacs Shane Will...
(CH. OPERATING & FINANCIAL OFF.) |
S | Common Stock | D | 18742 | $13.89 - $15.27 | $269,655 |
| 2023-11-20 | Olema Pharmaceuticals, Inc. | Kovacs Shane Will...
(CH. OPERATING & FINANCIAL OFF.) |
A | Common Stock | A | 36750 | $0.00 - $0.00 | $0 |
| 2023-11-08 | Olema Pharmaceuticals, Inc. | Myles David C.
(CH. DISCOV. & NON-CLIN DEV OFF) |
S | Common Stock | D | 200 | $17.61 - $17.61 | $3,522 |
| 2023-11-01 | Olema Pharmaceuticals, Inc. | Myles David C.
(CH. DISCOV. & NON-CLIN DEV OFF) |
S | Common Stock | D | 10541 | $15.02 - $17.51 | $160,804 |
| 2023-10-31 | Olema Pharmaceuticals, Inc. | Harmon Cyrus
(Director) |
S | Common Stock | D | 30000 | $12.05 - $15.64 | $379,450 |
Activity types
| A | Grant, award or other acquisition |
| C | Conversion of Derivative or Security |
| D | Disposition to the issuer of issuer equity securities |
| E | Expiration of short derivative position |
| F | Payment of exercise price or tax liability |
| G | Bona fide Gift |
| H | Expiration (or cancellation) of long derivative position with value received |
| I | Discretionary Transaction |
| J | Other acquisition or disposition |
| K | Transaction in equity swap or instrument with similar characteristics |
| L | Small Acquisition |
| M | Exercise or conversion of derivative security |
| O | Exercise of out-of-the-money derivative security |
| P | Open Market Purchase |
| S | Open Market Sale |
| U | Disposition pursuant to a tender of shares in a change of control transaction |
| V | Transaction Voluntarily Reported |
| X | Exercise of in-the-money or at-the-money derivative security |
| Z | Deposit into or withdrawal from voting trust |